• Vol. 52 No. 2, 100–104
  • 24 February 2023

Safety and effectiveness of nitrous oxide procedural sedation in a paediatric emergency department

1262






0 Citing Article
1262 Views
402 Downloads

Download PDF

Dear Editor,

Nitrous oxide (N2O) produces dissociative euphoria, amnesia and analgesia, and is a common sedative for procedural sedation in paediatric emergency departments (EDs) due to its non-parenteral administration and good safety profile.1-3 Suitable procedures include fracture reduction, toilet and suturing, incision and drainage, and application of burn dressings. The concentration of N2O administered ranges from 30–70%, with maximum effect at 5 minutes, and rapid recovery upon discontinuation.1,4 Co-administered medications include intranasal fentanyl (1.5μg/kg, maximum 100μg/dose) administered 30–60 minutes prior to enhance analgesia,3 oral analgesics, topical anaesthesia or parenteral morphine.

Although N2O is commonly used globally, there is no published report on its effectiveness and safety in paediatric patients in Singapore. We seek to identify the effectiveness of N2O as a form of procedural sedation and analgesia for children requiring painful procedures in a tertiary paediatric emergency department (ED), study the incidence of adverse events, and evaluate the safety of co-administered opioids.

A retrospective analysis was performed on all patients less than 18 years who underwent procedural sedation with N2O as a primary agent from 1 April 2013 to 31 September 2021, at the ED of KK Women’s and Children’s Hospital, Singapore. A prospective electronic database of all procedural sedations performed at the ED was set up in April 2013. All sedation-related adverse events and interventions were prospectively documented in the sedation forms in the medical records and extracted into the database. Data on demographics, diagnosis, procedures, types of sedatives, other co-administered medications, adverse events, and interventions were electronically extracted from the database. N2O concentration, flow rate, start and end times, and sedation depth (Children’s Hospital of Wisconsin Sedation Scale)5 were extracted manually from electronic medical records. The Children’s Hospital of Wisconsin Sedation Scale has a scale of 0–6, with 6 being agitated. Data were anonymised in password-protected Excel (Microsoft Corp, Redmond, US) file.

Statistical analyses were performed using SPSS Statistics version 28.0 (IBM Corp, Armonk, US). Categorical variables were analysed using Fisher’s Exact test and continuous variables using independent t‐test. Univariate regression analyses were performed to identify predictors of adverse events. Variables with P value <0.1 in the univariate analysis were included in a multivariate logistic model to identify independent predictors.

In the study period from April 2013 to September 2021, 918 children underwent N2O sedation (Table 1). The median age was 11.91 (interquartile range [IQR] 9.26–13.90) years. Majority were male (75.4%). The most common diagnosis was fracture/dislocation requiring manipulation and reduction (98.3%). The mean duration of sedation was 15±9 minutes, and the mean duration of recovery was 3±4 minutes (n=511). A total of 93.1% received 50–70% N2O, while 177 (19.3%) received pre-planned local/topical analgesia.

Table 1. Baseline characteristics, procedural details and adverse events for patients who underwent sedation with nitrous oxide

Nine hundred patients (98%) had their procedures successfully completed using N2O sedation, with or without pre-planned oral, intranasal or topical analgesia. Most (97.2%) achieved a sedation scale of 3–5 (minimal to moderate sedation), with a mean decrease in sedation scale of 0.25±0.62 (n=386). Five (1.3%) had sedation scale ≤2. Of the remaining 18 patients, six (0.7%) received Bier’s block (2 for inadequate sedation, 2 given prior to N2O sedation and 2 given concurrently). Twelve (1.3%) patients required intramuscular (IM) ketamine subsequently. None received intravenous (IV) ketamine.

Sixteen (1.7%) patients had sedation-related adverse events, of whom 2 received IM ketamine subsequently, and 14 (1.5%) received N2O only (Table 1). Most events were minor: emesis (n=14, 1.5%), desaturation (n=1, 0.1%), and agitation (n=1, 0.1%). Twelve required no intervention, 2 required supplemental oxygen (one given prophylactically for agitation), and 2 required oral ondansetron. None required assisted ventilation or cardiopulmonary resuscitation. None were admitted for sedation-related events. Patients with adverse events (median age 9.90, IQR 6.88–12.05) were significantly younger than those without (median age 11.95, IQR 9.51–13.91, P=0.009). There was no significance between N2O concentration and adverse events (P=1.000).

In the univariate analysis (Table 1), intranasal fentanyl (odds ratio [OR] 2.692, 95% CI 0.587–12.346, P=0.202) or morphine (OR 1.519, 95% CI 0.194–11.879, P=0.690) was not associated with increased adverse events. For patients receiving intranasal fentanyl and N2O, 2/56 (3.6%) required ketamine due to unsuccessful procedures. Neither had adverse events. In contrast, for patients receiving morphine and N2O, 2/46 (4.3%) required ketamine, and both had adverse events (one desaturation to 91% and one emesis) (OR 4.61, 95% CI 1.266–16.784, P=0.020).

Among patients who received subsequent IM ketamine, 2/12 (16.7%) had adverse events (OR 12.743, 95% CI 2.554–63.581, P=0.002). This was still significant (adjusted OR 11.553, 95% CI 2.227–59.943, P=0.004) after adjusting for age as a covariate in multivariate analysis. Older children have been observed to have increased emesis risk with IM ketamine.6

The risk of emesis for co-administered intranasal fentanyl with N2O was reported to be 10–27.5%, with increased rates at 70% N2O.3,7 In our study, the emesis rate was 1.4% with N2O alone, and 3.7% (2/54) for intranasal fentanyl with N2O. This is also lower than the emesis rates (8.4%) with IM ketamine sedation reported.6 The risk of oxygen desaturation during N2O sedation in our study was 0.1%, compared to 1.9% with IM ketamine sedation.8 N2O sedation is a safe and effective alternative with a short recovery time if only mild to moderate depth of sedation is required.

In our study, the risk of adverse events was higher when subsequent IM ketamine was given after N2O sedation with co-administered parenteral morphine, compared with co-administered intranasal fentanyl. When additional analgesia with opioids is indicated with N2O sedation, intranasal fentanyl is a preferred option compared to parenteral morphine.

A limitation of our study was that delayed events were not included as most patients were discharged after 30 minutes. However, the incidence is likely rare, as N2O-related emesis is related to the duration of exposure, insignificant up to 1 hour.9

In summary, N2O is safe for paediatric sedation, with or without adjunct opioids. However, caution should be taken when a third sedative is added. We experienced a low incidence of adverse events, likely also contributed by close supervision and adherence to department protocols.

REFERENCES

  1. Krauss B, Green SM. Procedural sedation and analgesia in children. Lancet 2006;367:766-80.
  2. Pedersen RS, Bayat A, Steen NP, et al. Nitrous oxide provides safe and effective analgesia for minor paediatric procedures–a systematic review. Dan Med J 2013;60:A4627.
  3. Seith RW, Theophilos T, Babl FE. Intranasal Fentanyl and High-concentration Inhaled Nitrous Oxide for Procedural Sedation: A Prospective Observational Pilot Study of Adverse Events and Depth of Sedation. Acad Emerg Med 2012;19:31-6.
  4. Yee R, Wong D, Chay PL, et al. Nitrous oxide inhalation sedation in dentistry: An overview of its applications and safety profile. Singapore Dent J 2019;39:11-9.
  5. Hoffman GM, Nowakowski R, Troshynski TJ, et al. Risk Reduction in Pediatric Procedural Sedation by Application of an American Academy of Pediatrics/American Society of Anesthesiologists Process Model. Pediatrics 2002;109:236-43.
  6. Suryaprakash S, Tham LP. Predictors of emesis in children undergoing procedural sedation with intramuscular ketamine in a paediatric emergency department. Singapore Med J 2017;58:660-5.
  7. Seiler M, Staubli G, Landolt MA. Combined nitrous oxide 70% with intranasal fentanyl for procedural analgosedation in children: a prospective, randomised, double-blind, placebo-controlled trial. Emerg Med J 2019;36:142-7.
  8. Lee JL, Tham LP. Incidence and predictors of respiratory adverse events in children undergoing procedural sedation with intramuscular ketamine in a paediatric emergency department. Singapore Med J 2020;63:28-34.
  9. Peyton PJ, Wu CY. Nitrous Oxide-related Postoperative Nausea and Vomiting Depends on Duration of Exposure. Anesthesiology 2014;120:1137-45.